Clene Inc.Clene Inc.Clene Inc.

Clene Inc.

No trades
See on Supercharts
Market capitalization
‪47.75 M‬USD
−0.4765USD
‪−49.50 M‬USD
‪654.00 K‬USD
‪73.58 M‬
Beta (1Y)
−1.33

About Clene Inc.

CEO
Robert Dee Etherington
Headquarters
Salt Lake City
Website
Employees (FY)
85
Founded
2013
FIGI
BBG00YQ7WGM6
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.